Gibbs Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
10,713
+5,353
+100% +$748K 0.17% 120
2025
Q4
$894K Buy
+5,360
New +$840K 0.22% 111

Other funds holding RGEN

Gibbs Wealth Management's RGEN Position: Q1 2026 in Review

Gibbs Wealth Management increased its Repligen (RGEN) stake by 100% in Q1 2026, buying an estimated $748K and bringing the position to 10,713 shares worth $1.26M. The position accounts for 0.17% of the portfolio, ranked #120.

Gibbs Wealth Management first reported a position in RGEN in Q4 2025 and has held it in 2 quarters since. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Gibbs Wealth Management held 10,713 shares of Repligen worth $1.26M as of Q1 2026.
  • Gibbs Wealth Management bought 5,353 Repligen shares in Q1 2026, an estimated $748K.
  • Repligen made up 0.17% of Gibbs Wealth Management's portfolio in Q1 2026, its #120 holding.
  • Gibbs Wealth Management first reported a position in Repligen in Q4 2025 and has held it in 2 quarters since.
  • 445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.